Created in 2007 (France), NUCLISENS own 144 sister brands and 2617 competing brands. NUCLISENS is a brand of BIOMERIEUX, listed on the stock exchange of Paris. The ISIN, the company's International Securities Identification Number, is FR0013280286. NUCLISENS belongs to the Medical Diagnostics & Research business sector.
Investment simulator :
Portfolio valuation
BIOMERIEUX
(NUCLISENS)
over 5 years*
EUR 125.37